BR100 Decreased By (-0.21%)
BR30 Decreased By (-0.19%)
KSE100 Decreased By (-0.04%)
KSE30 Decreased By (-0.12%)
AGHA 7.80 Decreased By ▼ -0.01 (-0.13%)
BECO 5.18 Decreased By ▼ -0.03 (-0.58%)
BML 57.50 No Change ▼ 0.00 (0%)
BOP 33.80 Decreased By ▼ -0.23 (-0.68%)
CNERGY 10.01 Increased By ▲ 0.05 (0.5%)
CSIL 5.32 Increased By ▲ 0.01 (0.19%)
FCCL 54.00 Decreased By ▼ -0.70 (-1.28%)
FFL 16.62 Decreased By ▼ -0.07 (-0.42%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 7.35 Decreased By ▼ -0.05 (-0.68%)
KOSM 5.71 Decreased By ▼ -0.06 (-1.04%)
LOTCHEM 29.15 Decreased By ▼ -0.17 (-0.58%)
MLCF 93.30 Decreased By ▼ -1.06 (-1.12%)
NBP 202.35 Decreased By ▼ -0.70 (-0.34%)
NCPL 56.32 Decreased By ▼ -0.68 (-1.19%)
NPL 67.45 Decreased By ▼ -0.25 (-0.37%)
OGDC 316.00 Increased By ▲ 0.16 (0.05%)
PACE 10.64 No Change ▼ 0.00 (0%)
PAEL 42.90 Decreased By ▼ -0.30 (-0.69%)
PIBTL 16.60 Decreased By ▼ -0.14 (-0.84%)
PPL 218.39 Decreased By ▼ -1.39 (-0.63%)
PRL 49.79 Increased By ▲ 0.60 (1.22%)
PTC 70.65 Increased By ▲ 0.12 (0.17%)
SSGC 27.93 Decreased By ▼ -0.32 (-1.13%)
TBL 9.83 Decreased By ▼ -0.03 (-0.3%)
TELE 8.70 Decreased By ▼ -0.09 (-1.02%)
TPL 18.00 Decreased By ▼ -0.24 (-1.32%)
TPLP 13.37 Increased By ▲ 0.10 (0.75%)
TREET 22.68 Decreased By ▼ -0.04 (-0.18%)
TRG 60.00 Decreased By ▼ -0.14 (-0.23%)
Markets

CBOT soybeans to test resistance at $12.69-1/4

8 The contract is riding on a wave 3 that is travelling towards the range of $12.69-1/4 to $12.77-3/4, formed by its 338.2% and 361.8% projection levels.
Published Updated
By

SINGAPORE: The CBOT soybean January contract is expected to test a resistance at $12.69-1/4 per bushel, with a good chance of breaking above this level and rising towards $12.77-3/4.

The contract is riding on a wave 3 that is travelling towards the range of $12.69-1/4 to $12.77-3/4, formed by its 338.2% and 361.8% projection levels.

Support is at $12.61, a break below which may cause a fall into $12.51-$12.56 range.

Each reader should consult his or her own professional or other advisers for business, financial or legal advice regarding the products mentioned in the analyses.

Comments

Comments are closed for this article.